Description

Advanced, FDA-approved weight loss—prescribed fully online.

Zepbound® is a once-weekly, dual-acting GLP-1/GIP medication powered by tirzepatide that targets appetite and metabolism through multiple pathways. In clinical trials, patients achieved up to 20.9% average body-weight reductionwhen combined with lifestyle changes. Zepbound® may also improve blood pressure, cholesterol levels, and insulin sensitivity—supporting overall metabolic health.

How It Works with ReMDi
Zepbound® is prescribed through a ReMDi Health subscription, which includes a personalized medical evaluation, lab review, and ongoing clinical guidance from a licensed provider. If prescribed, medication is delivered directly to your home through LillyDirect or your pharmacy of choice.

Treatment Details

• Once-weekly injection
• Dual GLP-1/GIP metabolic support
• Personalized care plan with a licensed provider
• Ongoing prescription management
• Unlimited messaging with the ReMDi Care Team

Insurance & Cost
Zepbound® may be covered by insurance, depending on your plan. Coverage varies by carrier and benefit design.

Medication cost is not included in the ReMDi Health subscription. A ReMDi subscription is required to receive a prescription.